Abstract
Rationale
The use of ecstasy (MDMA) among young adults has dramatically increased over the years. Since MDMA may impair the users' driving ability, the risk of being involved in a motor vehicle accident (MVA) is notably increased. Minimal traumatic brain injury (mTBI) a common consequence of MVAs—produces short- and long-term physical, cognitive, and emotional impairments.
Objectives
To investigate the effects of an acute dose of MDMA in mice subjected to closed head mTBI.
Methods
Mice received 10 mg/kg MDMA 1 h prior to the induction of mTBI. Behavioral tests were conducted 7 and 30 days post-injury. In addition to the behavioral tests, phosphorylation of IGF-1R, ERK, and levels of tyrosine hydroxylase (TH) were measured.
Results
mTBI mice showed major cognitive impairments in all cognitive tests conducted. No additional impairments were seen if mTBI was preceded by one dose of MDMA. On the contrary, a beneficial effect was seen in these mice. The western blot analysis of TH revealed a significant decrease in the mTBI mice. These decreases were reversed in mice that were subjected to MDMA prior to the trauma.
Conclusions
The presence of MDMA at the time of mTBI minimizes the alteration of visual and spatial memory of the injured mice. The IGF-1R pathway was activated due to mTBI and MDMA but was not the main contributor to the cognitive improvements. MDMA administration inverted the TH decreases seen after injury. We believe this may be the major cause of the cognitive improvements seen in these mice.
Similar content being viewed by others
References
Able JA, Guldelsky GA, Vorhees CV, Williams MT (2006) 3,4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory. Biol Psychiatry 59:1219–1226
Alcalay RN, Giladi E, Pick CG, Gozes I (2004) Intranasal administration of NAP, a neuroprotective peptide, decreases anxiety-like behavior in aging mice in the elevated plus maze. Neurosci Lett 361:128–131
Alexander MP (1995) Mild traumatic brain injury—pathophysiology, natural-history, and clinical management. Neurology 45:1253–1260
Bales JW, Wagner AK, Kline AE, Dixon CE (2009) Persistent cognitive dysfunction after traumatic brain injury: a dopamine hypothesis. Neurosci Biobehav Rev 33:981–1003
Baratz R, Rubovitch V, Frenk H, Pick CG (2010) The influence of alcohol on behavioral recovery after mTBI in mice. J Neurotrauma 27:555–563
Bayir H, Kagan VE (2008) Bench-to-bedside review: mitochondrial injury, oxidative stress and apoptosis—there is nothing more practical than a good theory. Critical Care 12:206
Bazarian JJ, McClung J, Shah MN, Cheng YT, Flesher W, Kraus J (2005) Mild traumatic brain injury in the United States, 1998–2000. Brain Inj 19:85–91
Brookhuis KA, de Waard D, Samyn N (2004) Effects of MDMA (ecstasy), and multiple drugs use on (simulated) driving performance and traffic safety. Psychopharmacology 173:440–445
Brown PL, Kiyatkin EA (2004) Brain hyperthermia induced by MDMA (‘ecstasy’): modulation by environmental conditions. Eur J Neurosci 20:51–58
Bullinger M (2002) Quality of life in patients with traumatic brain injury—basic issues, assessment and recommendations—results of a consensus meeting. Restor Neurol Neurosci 20:111–124
Cadet JL, Thiriet N, Jayanthi S (2001) Involvement of free radicals in MDMA-induced neurotoxicity in mice. Ann Méd Interne 152:S57–S59
Camarasa J, Marimon JM, Rodrigo T, Escubedo E, Pubill D (2008) Memantine prevents the cognitive impairment induced by 3,4-methylenedioxymethamphetamine in rats. Eur J Pharmacol 589:132–139
Camarero J, Sanchez V, O’Shea E, Green AR, Colado MI (2002) Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine (‘ecstasy’)-induced dopamine release and free radical formation in the mouse striatum. J Neurochem 81:961–972
Capela JP, Fernandes E, Remiao F, Bastos ML, Meisel A, Carvalho F (2007) Ecstasy induces apoptosis via 5-HT2A-receptor stimulation in cortical neurons. Neurotoxicology 28:868–875
Capela JP, Carmo H, Remiao F, Bastos ML, Meisel A, Carvalho F (2009) Molecular and cellular mechanisms of ecstasy-induced neurotoxicity: an overview. Mol Neurobiol 39:210–271
Carvalho M, Carvalho F, Remiao F, Pereira MD, Pires-das-Neves R, Bastos MD (2002) Effect of 3,4-methylenedioxymethampheta mine (“ecstasy”) on body temperature and liver antioxidant status in mice: influence of ambient temperature. Arch Toxicol 76:166–172
Cassidy JD, Carroll LJ, Peloso PM, Borg J, von Holst H, Holm L, Kraus J, Coronado VG (2004) Incidence, risk factors and prevention of mild traumatic brain injury: results of the WHO collaborating centre task force on mild traumatic brain injury. J Rehabil Med 36:28–60
Cheng CM, Mervis RF, Niu SL, Salem N, Witters LA, Tseng V, Reinhardt R, Bondy CA (2003) Insulin-like growth factor 1 is essential for normal dendritic growth. J Neurosci Res 73:1–9
Chong ZZ, Li FQ, Maiese K (2005) Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease. Prog Neurobiol 75:207–246
Colado MI, Camarero J, Meehan AO, Sanchez V, Esteban B, Elliott JM, Green AR (2001) A study of the mechanisms involved in the neurotoxic action of 3, 4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’) on dopamine neurones in mouse brain. Br J Pharmacol 134:1711–1723
Colado MI, O'Shea E, Green AR (2004) Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function. Psychopharmacology 173:249–263
Conrad CD, Galea LAM, Kuroda Y, McEwen BS (1996) Chronic stress impairs rat spatial memory on the Y maze, and this effect is blocked by tianeptine pretreatment. Behav Neurosci 110:1321–1334
Darke S, Kelly E, Ross J (2004) Drug driving among injecting drug users in Sydney, Australia: prevalence, risk factors and risk perceptions. Addiction 99:175–185
Dellu F, Mayo W, Cherkaoui J, Lemoal M, Simon H (1992) A 2-trial memory task with automated recording—study in young and aged rats. Brain Res 588:132–139
Dhillon HS, Dose JM, Prasad RM (1998) Amphetamine administration improves neurochemical outcome of lateral fluid percussion brain injury in the rat. Brain Res 804:231–237
Donnemiller E, Brenneis C, Wissel J, Scherfler C, Poewe W, Riccabona G, Wenning GK (2000) Impaired dopaminergic neurotransmission in patients with traumatic brain injury: a SPET study using I-123-beta-CIT and I-123-IBZM. Eur J Nucl Med 27:1410–1414
Drummer OH, Gerostamoulos J, Batziris H, Chu M, Caplehorn JRM, Robertson MD, Swann P (2003) The incidence of drugs in drivers killed in Australian road traffic crashes. Forensic Sci Int 134:154–162
Evans RW, Gualtieri CT, Patterson D (1987) Treatment of chronic closed head-injury with psychostimulant drugs—a controlled case-study and an appropriate evaluation procedure. J Nerv Ment Dis 175:106–110
Fantegrossi WE, Ciullo JR, Wakabayashi KT, De la Garza R, Traynor JR, Woods JH (2008) A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3, 4-methylenedioxymethamphetamine in the mouse. Neuroscience 151:533–543
Fleminger S (2008) Long-term psychiatric disorders after traumatic brain injury. Eur J Anaesthesiol Suppl 42:123–130
Fujimoto ST, Longhi L, Saatman KE, McIntosh TK (2004) Motor and cognitive function evaluation following experimental traumatic brain injury. Neurosci Biobehav Rev 28:365–378
Gennarelli TA, Champion HR, Copes WS, Sacco WJ (1994) Comparison of mortality, morbidity, and severity of 59,713 head-injured patients with 114,447 patients with extracranial injuries. J Trauma Inj Infect Crit Care 37:962–968
Graham DI, McIntosh TK, Maxwell WL, Nicoll JAR (2000) Recent advances in neurotrauma. J Neuropathol Exp Neurol 59:641–651
Granado N, Escobedo I, O'Shea E, Colado MI, Moratalla R (2008) Early loss of dopaminergic terminals in striosomes after MDMA administration to mice. Synapse 62:80–84
Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA, “ecstasy”). Pharmacol Rev 55:463–508
Green AR, Gabrielsson J, Marsden CA, Fone KCF (2009) MDMA: on the translation from rodent to human dosing. Psychopharmacology 204:375–378
Guan J, Bennet L, Gluckman PD, Gunn AJ (2003) Insulin-like growth factor-1 and post-ischemic brain injury. Prog Neurobiol 70:443–462
Gudelsky GA, Yamamoto BK (2008) Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons. Pharmacol Biochem Behav 90:198–207
Haavik J, Toska K (1998) Tyrosine hydroxylase and Parkinson's disease. Mol Neurobiol 16:285–309
Hamm RJ, Lyeth BG, Jenkins LW, Odell DM, Pike BR (1993) Selective cognitive impairment following traumatic brain injury in rats. Behav Brain Res 59:169–173
Hammond RS, Tull LE, Stackman RW (2004) On the delay-dependent involvement of the hippocampus in object recognition memory. Neurobiol Learn Mem 82:26–34
Henry JM, Talukder NK, Lee AB, Walker ML (1997) Cerebral trauma-induced changes in corpus striatal dopamine receptor subtypes. J Investig Surg 10:281–286
Hogg S (1996) A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54:21–30
Hooft PJ, Vandevoorde HP (1994) Reckless behavior related to the use of 3,4-methylenedioxymethamphetamine (ecstasy)—apropos of a fatal accident during car-surfing. Int J Leg Med 106:328–329
Kern CH, Stanwood GD, Smith DR (2009) Preweaning manganese exposure causes hyperactivity, disinhibition, and spatial learning and memory deficits associated with altered dopamine receptor and transporter levels. Synapse 64:363–378
Kleim JA, Jones TA, Schallert T (2003) Motor enrichment and the induction of plasticity before or after brain injury. Neurochem Res 28:1757–1769
Kumer SC, Vrana KE (1996) Intricate regulation of tyrosine hydroxylase activity and gene expression. J Neurochem 67:443–462
Kushner D (1998) Mild traumatic brain injury—toward understanding manifestations and treatment. Arch Intern Med 158:1617–1624
Kuypers KPC, Bosker WM, Ramaekers JG (2009) Ecstasy, driving and traffic safety. In: Joris C. Verster, S. R. Pandi-Perumal, Jan G. Ramaekers (eds.) Drugs, driving and traffic safety 501–518 Switzerland: Birkhauser Verlag AG
Logan BK, Couper FJ (2001) 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment. J Forensic Sci 46:1426–1433
Maas AIR, Stocchetti N, Bullock R (2008) Moderate and severe traumatic brain injury in adults. Lancet Neurol 7:728–741
Margulies S (2000) The postconcussion syndrome after mild head trauma: is brain damage overdiagnosed? Part 1. J Clin Neurosci 7:400–408
McBeth BD, Stern SA, Wang X, Mertz M, Zink BJ (2005) Effects of cocaine in an experimental model of traumatic brain injury. Acad Emerg Med 12:483–490
McGregor IS, Clemens KJ, Van der Plasse G, Li KM, Hunt GE, Chen F, Lawrence AJ (2003) Increased anxiety 3 months after brief exposure to MDMA (“ecstasy”) in rats: association with altered 5-HT transporter and receptor density. Neuropsychopharmacology 28:1472–1484
McIntosh TK, Yu T, Gennarelli TA (1994) Alterations in regional brain catecholamine concentrations after experimental brain injury in the rat. J Neurochem 63:1426–1433
Milman A, Rosenberg A, Weizman R, Pick CG (2005) Mild traumatic brain injury induces persistent cognitive deficits and behavioral disturbances in mice. J Neurotrauma 22:1003–1010
Milman A, Weizman R, Rigai T, Rice KC, Pick CG (2006) Behavioral effects of opioid subtypes compared with benzodiazepines in the staircase paradigm. Behav Brain Res 170:141–147
Milman A, Zohar O, Maayan R, Weizman R, Pick CG (2008) DHEAS repeated treatment improves cognitive and behavioral deficits after mild traumatic brain injury. Eur Neuropsychopharmacol 18:181–187
Morales DM, Marklund N, Lebold D, Thompson HJ, Pitkanen A, Maxwell WL, Longhi L, Laurer H, Maegele M, Neugebauer E, Graham DI, Stocchetti N, McIntosh TK (2005) Experimental models of traumatic brain injury: do we really need to build a better mousetrap? Neuroscience 136:971–989
Morgan MJ (2000) Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology 152:230–248
Morris RGM (1981) Spatial localization does not require the presence of local cues. Learn Motiv 12:239–260
Morton J (2005) Ecstasy: pharmacology and neurotoxicity. Curr Opin Pharmacol 5:79–86
Movig KLL, Mathijssen MPM, Nagel PHA, van Egmond T, de Gier JJ, Leufkens HGM, Egberts ACG (2004) Psychoactive substance use and the risk of motor vehicle accidents. Accid Anal Prev 36:631–636
Nochajski TH, Stasiewicz PR (2006) Relapse to driving under the influence (DUI): a review. Clin Psychol Rev 26:179–195
O’Phelan K, McArthur DL, Chang CWJ, Green D, Hovda DA (2008) The impact of substance abuse on mortality in patients with severe traumatic brain injury. J Trauma Inj Infect Crit Care 65:674–677
Petrasek T, Stuchlik A (2009) Serotonin-depleted rats are capable of learning in active place avoidance, a spatial task requiring cognitive coordination. Physiol Res 58:299–303
Pick CG, Cheng J, Paul D, Pasternak GW (1991) Genetic influences in opioid analgesic sensitivity in mice. Brain Res 566:295–298
Pick CG, Peter Y, Schreiber S, Weizman R (1997) Pharmacological characterization of buprenorphine, a mixed agonist-antagonist with kappa 3 analgesia. Brain Res 744:41–46
Piper BJ, Meyer JS (2004) Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period. Pharmacol Biochem Behav 79:723–731
Piper BJ, Fraiman JB, Meyer JS (2005) Repeated MDMA (“ecstasy”) exposure in adolescent male rats alters temperature regulation, spontaneous motor activity, attention, and serotonin transporter binding. Dev Psychobiol 47:145–157
Rubovitch V, Edut S, Sarfstein R, Werner H, Pick CG (2010) The intricate involvement of the insulin-like growth factor receptor signaling in mild traumatic brain injury in mice. Neurobiol Dis 2:299–303
Ryan LM, Warden DL (2003) Post concussion syndrome. Int Rev Psychiatry 15:310–316
Schreiber S, Barkai G, Gur-Hartman T, Peles E, Tov N, Dolberg OT, Pick CG (2008) Long-lasting sleep patterns of adult patients with minor traumatic brain injury (mTBI) and non-mTBI subjects. Sleep Med 9:481–487
Shein NA, Horowitz M, Shohami E (2007) Heat acclimation: a unique model of physiologically mediated global preconditioning against traumatic brain injury. In: Weber JT, Maas AIR (eds) Neurotrauma: new insights into pathology and treatment (progress in brain research). Elsevier, Amsterdam, pp 353–363
Shohami E, Gati I, Beit-Yannai E, Trembovler V, Kohen R (1999) Closed head injury in the rat induces whole body oxidative stress: overall reducing antioxidant profile. J Neurotrauma 16:365–376
Simola N, Di Chiara G, Daniels WMU, Schallert T, Morelli M (2009) Priming of rotational behavior by a dopamine receptor agonist in Hemiparkinsonian rats: movement-dependent induction. Neuroscience 158:1625–1631
Skelton MR, Able JA, Grace CE, Herring R, Schaefer TL, Gudelsky GA, Vorhees CV, Williams MT (2008) (+/−)-3,4-Methylenedioxymethamphetamine treatment in adult rats impairs path integration learning: a comparison of single vs once per week treatment for 5 weeks. Neuropharmacology 55:1121–1130
Smink BE, Movig KLL, Lusthof KJ, De Gier JJ, Uges DRA, Egberts ACG (2008) The relation between the use of psychoactive substances and the severity of the injury in a group of crash-involved drivers admitted to a regional trauma center. Traffic Inj Prev 9:105–108
Sosnoff JJ, Broglio SP, Ferrara MS (2008) Cognitive and motor function are associated following mild traumatic brain injury. Exp Brain Res 187:563–571
Sprague JE, Preston AS, Leifheit M, Woodside B (2003) Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning. Physiol Behav 79:281–287
Tang YP, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, Liu GS, Tsien JZ (1999) Genetic enhancement of learning and memory in mice. Nature 401:63–69
Tashlykov V, Katz Y, Gazit V, Zohar O, Schreiber S, Pick CG (2007) Apoptotic changes in the cortex and hippocampus following minimal brain trauma in mice. Brain Res 1130:197–205
Tashlykov V, Katz Y, Volkov A, Gazit V, Schreiber S, Zohar O, Pick CG (2009) Minimal traumatic brain injury induce apoptotic cell death in mice. J Mol Neurosci 37:16–24
Tweedie D, Milman A, Holloway HW, Li YZ, Harvey BK, Shen H, Pistell PJ, Lahiri DK, Hoffer BJ, Wang Y, Pick CG, Greig NH (2007) Apoptotic and behavioral sequelae of mild brain trauma in mice. J Neurosci Res 85:805–815
Vos PE, Battistin L, Birbamer G, Gerstenbrand F, Potapov A, Prevec T, Stepan CA, Traubner P, Twijnstra A, Vecsei L, von Wild K (2002) EFNS guideline on mild traumatic brain injury: report of an EFNS task force. Eur J Neurol 9:207–219
Wagner AK, Chen XB, Kline AE, Li YM, Zafonte RD, Dixon CE (2005a) Gender and environmental enrichment impact dopamine transporter expression after experimental traumatic brain injury. Exp Neurol 195:475–483
Wagner AK, Sokoloski JE, Ren D, Chen X, Khan AS, Zafonte RD, Michael AC, Dixon CE (2005b) Controlled cortical impact injury affects dopaminergic transmission in the rat striatum. J Neurochem 95:457–465
Wagner AK, Drewencki LL, Chen X, Santos FR, Khan AS, Harun R, Torres GE, Michael AC, Dixon CE (2009) Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injury. J Neurochem 108:986–997
Warren MW, Kobeissy FH, Liu MC, Svetlov SI, Hayes RL, Gold MS, Wang KKW (2006) Ecstasy toxicity: a comparison to methamphetamine and traumatic brain injury. J Addict Dis 25:115–123
Warren MW, Larner SF, Kobeissy FH, Brezing CA, Jeung JA, Hayes RL, Gold MS, Wang KKW (2007) Calpain and caspase proteolytic markers co-localize with rat cortical neurons after exposure to methamphetamine and MDMA. Acta Neuropathol 114:277–286
Weinbroum AA (2003) Importance of early identification of methylenedioxymethamphetamine (‘ecstasy’) ingestion in victims of motor vehicle accidents. Eur J Emerg Med 10:19–22
Weizman R, Paz L, Peter Y, Pick CG (2001) Mice performance on the staircase test following acute ethanol administration. Pharmacol Biochem Behav 68:491–495
Whishaw IQ, Tomie JA (1996) Of mice and mazes: similarities between mice and rats on dry land but not water mazes. Physiol Behav 60:1191–1197
Yan HQ, Li Y, Ma X, Marion DW, Dixon CE (2001) Traumatic brain injury (TBI) causes decreased expression of dopamine transporter protein in rat frontal cortex. Society for Neuroscience Abstracts 27:567
Yan HQ, Kline AE, Ma XC, Li YM, Dixon CE (2002) Traumatic brain injury reduces dopamine transporter protein expression in the rat frontal cortex. NeuroReport 13:1899–1901
Zohar O, Schreiber S, Getslev V, Schwartz JP, Mullins PG, Pick CG (2003) Closed-head minimal traumatic brain injury produces long-term cognitive deficits in mice. Neuroscience 118:949–955
Zohar O, Getslev V, Miller AL, Schreiber S, Pick CG (2006) Morphine protects for head trauma induced cognitive deficits in mice. Neurosci Lett 394:239–242
Acknowledgments
This study was supported (in part) by a grant from the Dr. Herman Schauder Endownment Fund for Research and by a grant from The Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases, Tel Aviv University, Tel Aviv, Israel.
Role of funding source
None declared.
Contributors
Shahaf Edut and Chaim Pick designed the study and wrote the protocol, as well as designed the behavioral experiments and contributed to the interpretations of the results. Shahaf Edut managed the literature searches and analyses. Shahaf Edut and Vardit Rubovitch undertook the statistical analysis, and Shahaf Edut wrote the first draft of the manuscript. All authors contributed to and have approved the final manuscript.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Edut, S., Rubovitch, V., Schreiber, S. et al. The intriguing effects of ecstasy (MDMA) on cognitive function in mice subjected to a minimal traumatic brain injury (mTBI). Psychopharmacology 214, 877–889 (2011). https://doi.org/10.1007/s00213-010-2098-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-010-2098-y